RSS

Korea

Swiss pharmaceutical group, Helsinn, and professional pharmaceutical subsidiary of CJ Group, CJ Healthcare, have announced that the oral formulation of AKYNZEO has been approved for use in Korea by the Korean Ministry of Food and Drug Safety (MFDS). more

News